AFT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AFT Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 4.39 NZD 1.86%

Market Cap: NZ$460.4m

A	AFT Pharmaceuticals Ltd NZX:AFT	NZ
	Rolls-Royce Holdings PLC OTC:RYCEF	UK

Profitability Summary

AFT Pharmaceuticals Ltd's profitability score is 50/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

43%

Sustainable 3Y Average Gross Margin

45%

Declining Gross Margin

47% > 43%

Low Operating Margin

10%

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

13% > 10%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

7% > 6%

Negative Free Cash Flow Margin

-8%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

2% > -8%

Positive ROE

14%

Positive 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

13% > 11%

View All

Hide

Collapse

50 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.